HK$3.35
0.15%
Hong Kong, Oct 20, 04:08 pm HKT. Closed.
ISIN
CNE100000171
Symbol
1066

Shandong Weigao Group Medical Polymer Stock price

HK$3.35
+0.22 7.04% 1M
-0.34 9.10% 6M
-1.68 33.37% YTD
-2.36 41.32% 1Y
-3.48 50.95% 3Y
-10.30 75.48% 5Y
-1.86 35.67% 10Y
+2.10 169.22% 20Y
Hong Kong, Closing price Fri, Oct 16 2026
-0.01 0.15%
ISIN
CNE100000171
Symbol
1066

Is Shandong Weigao Group Medical Polymer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$15.1b
Enterprise Value
HK$9.9b
Net debt
positive
Cash
HK$10.0b
Shares outstanding
4.5b
Valuation
P/E
9.3
P/S | estimate
0.9 | 0.9
EV/Sales | estimate
0.6 | 0.6
EV/FCF | ex SBC
3.1 | -
P/B
0.5
Dividends
DPS
HK$0.17
Yield 1Y | 5Y
5.2% | 2.1%
Growth 1Y | 5Y
-25.7% | 2.7%
Payout 1Y | 3Y
41.6% | 40.4%
Increased
0 Years
Financials
Revenue | estimate
HK$15.9b | HK$16.7b
EBITDA
-
EBIT
HK$2.4b
Net Income
HK$1.6b
Free Cash Flow | ex SBC
HK$3.2b | -
Growth
Revenue | estimate
3.8% | 6.7%
EBITDA
-
EBIT
-22.4%
Net Income
-30.0%
Free Cash Flow
3.7%
Margin
Gross
45.9%
EBITDA
-
EBIT
14.7%
Net
10.1%
Free Cash Flow | ex SBC
20.2% | -
Financial Health
Equity Ratio
66.9%
Return on Equity
6.7%
ROCE
6.9%
ROIC
7.3%
Debt/Equity
0.2
More
EPS
HK$0.4
FCF per Share
HK$0.7
Short interest
-
Employees
13k
Rev per Employee
HK$1.2m

Shandong Weigao Group Medical Polymer Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Shandong Weigao Group Medical Polymer forecast:

12x Buy
80%
3x Hold
20%

Analyst Opinions

15 Analysts have issued a Shandong Weigao Group Medical Polymer forecast:

Buy
80%
Hold
20%

Financial data from Shandong Weigao Group Medical Polymer

Jun '26
+/-
%
15,943 15,943
4% 4%
100%
- Direct Costs 8,625 8,625
12% 12%
54%
7,318 7,318
4% 4%
46%
- Selling and Administrative Expenses 4,415 4,415
3% 3%
28%
- Research and Development Expense 743 743
1% 1%
5%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 2,350 2,350
22% 22%
15%
Net Profit 1,616 1,616
30% 30%
10%

In millions HKD.

Don't miss a Thing! We will send you all news about Shandong Weigao Group Medical Polymer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. The company is headquartered in Weihai, Shandong and currently employs 12,719 full-time employees. The company went IPO on 2004-02-27. The firm operates six segments. Medical Device Products segment engaged in the production and sale of clinical care, medical testing, anesthesia and surgical related products and other consumables. Orthopaedic Products segment engaged in the production and sale of orthopaedic products, including tissue repair product line. Interventional Products segment engages in production and sale of tumor and blood vessel interventional instruments. Pharma Packaging Products segment includes production and sale of pre-filled syringes and flushing syringes. Blood Management Products segment includes production and sale of blood collection, irradiation, storage, separation and sterilization products. Others segment includes finance lease and factoring business.

Head office China
CEO Mr. Cong
Employees 13,307
Website www.weigaoholding.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today